:: Altroz - News Magazine HTML Template ::

Language:

Eli Lilly News

Eli Lilly Predicts Robust Revenue Growth, Eyes $58-61 Billion by 2025

Michael Lee 14 Jan, 2025

Eli Lilly and Company forecasts a significant revenue increase to $58-61 billion by 2025, driven by strong sales of its diabetes and obesity treatments, Mounjaro and Zepbound. CEO ...

Business

Eli Lilly Nears $2.5 Billion Deal to Acquire Scorpion Therapeutics

Olivia Carter 11 Jan, 2025

Eli Lilly and Company is reportedly finalizing a $2.5 billion acquisition of Scorpion Therapeutics, with a $1 billion upfront payment and up to $1.5 billion more based on performan...